Results 1 to 20 of 33
Page 1 of 2  Next >
Serum hepatitis B surface antigen levels to guide the cessation of entecavir in hepatitis B e antigen-negative chronic hepatitis B: an interim analysis. The International Liver Congress™ 2013 – 48<font size=-1><sup>th</sup></font> Annual meeting of the European Association for the Study of the Liver Amsterdam, The NetherlandsSeto, WKW; Hui, AJ; Wong, VWS; Wong, GLH; Liu, K; Lai, CL; Yuen, RMF; Chan, HLY201347
eGFR improvement in chronic hepatitis b patients with telbivudine treatment is independent of antiviral activityGane, EJ; Liaw, YF; Wang, Y; Lai, CL; Rasenack, J; Zeuzem, S; Chan, HLY; Ren, H; Dong, Y; Uddin, A; Jung, ME; Bosset, S; Trylesinski, A201330
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive scoreYang, HI; Yuen, MF; Chan, HLY; Han, KH; Chen, PJ; Kim, DY; Ahn, SH; Chen, CJ; Wong, VWS; Seto, WK2011967
Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in Hepatocellular carcinoma developmentYip, WK; Cheng, ASL; Zhu, R; Lung, RWM; Tsang, DPF; Lau, SSK; Chen, Y; Sung, JG; Lai, PBS; Ng, EKO; Yu, J; Wong, N; To, KF; Wong, VWS; Sung, JJY; Chan, HLY2011153
Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directionsAhn, SH; Chan, HLY; Chen, PJ; Cheng, J; Goenka, MK; Hou, J; Lim, SG; Omata, M; Piratvisuth, T; Xie, Q; Yim, HJ; Yuen, MF2010206
Efficacy of cap-assisted colonoscopy in comparison with regular colonoscopy: A randomized controlled trialLee, YT; Lai, LH; Hui, AJ; Wong, VWS; Ching, JYL; Wong, GLH; Wu, JCY; Chan, HLY; Leung, WK; Lau, JYW; Sung, JJY; Chan, FKL2009107
High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genomeDong, Q; Liu, Z; Chen, Y; Chan, CY; Lin, MC; Kung, Hf; Chan, HLY; Sung, JJY; He, ML2009146
High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis BWong, VWS; Yu, J; Cheng, ASL; Wong, GLH; Chan, HY; Chu, ESH; Ng, EKO; Chan, FKL; Sung, JJY; Chan, HLY2009229
Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific RegionAmarapurkar, D; Han, KH; Chan, HLY; Ueno, Y; Yuen, RMF2009323
Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized studyLee, YT; Chan, FKL; Leung, WK; Chan, HLY; Wu, JCY; Yung, MY; Ng, EKW; Lau, JYW; Sung, JJY2008100
Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitisYu, J; Chu, ESH; Hui, AY; Cheung, KF; Chan, HLY; Leung, WK; Farrell, GC; Sung, JJY2007112
Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitisYu, J; Hui, AY; Chu, ESH; Cheng, ASL; Go, MYY; Chan, HLY; Leung, WK; Cheung, KF; Ching, AKK; Chui, YL; Chan, KK; Sung, JJY200781
76 week follow up of HBeAg-positive chronic hepatitis B patients treated with telbivudine, adefovir or switched from adefovir to telbivudineMarcellin, P; Chan, HLY; Lai, CL; Cho, M; Moon, YM; Chao, YC; Heathcote, J; Myers, R; Harb, G; Brown, NA2007117
In hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacyMarcellin, P; Chan, HLY; Lai, CL; Clio, M; Heathcote, I; Moon, YM; Chao, YC; Myers, R; Harb, G; Brown, NA200794
Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trialChan, FKL; Wong, VWS; Suen, BY; Wu, JCY; Ching, JYL; Hung, LCT; Hui, AJ; Leung, VKS; Lee, VWY; Lai, LH; Wong, GLH; Chow, DKL; To, KF; Leung, WK; Chiu, PWY; Lee, YT; Lau, JYW; Chan, HLY; Ng, EKW; Sung, JJY2007123
Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trialChan, HLY; Heathcote, EJ; Marcellin, P; Lai, CL; Cho, M; Moon, YM; Chao, YC; Myers, RP; Minuk, GY; Jeffers, L; Sievert, W; Bzowej, N; Harb, G; Kaiser, R; Qiao, XJ; Brown, NA; Crawford, D; Lim, SG; Chutaputti, A; Poynard, T2007143
A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Final Week 52 resultsBzowej, N; Chan, HLY; Lai, CL; Cho, M; Moon, YM; Chao, YC; Heathcote, EJ; Myers, R; Minuk, G; Marcellin, P; Jeffers, L; Sievert, W; Kaiser, R; Harb, G; Chao, GC; Brown, NA2006164
A randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysisChan, HLY; Lai, CL; Cho, M; Heathcote, J; Moon, Y-M; Chao, Y-C; Myers, R; Minuk, G; Marcellin, P; Jeffers, L; Sievert, W; Kaiser, R; Chao, G; Brown, N2006117
Clinical significance of hepatic derangement in severe acute respiratory syndromeChan, HLY; Kwan, ACP; To, KF; Lai, ST; Chan, PKS; Leung, WK; Lee, N; Wu, A; Sung, JJY200581
Transmission of hepatitis B by human bite - Confirmation by detection of virus in saliva and full genome sequencingHui, AY; Hung, LCT; Tse, PCH; Leung, WK; Chan, PKS; Chan, HLY200567
Page 1 of 2  Next >
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download